Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuemang Yao

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2024
A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's diseaseYuemang Yao, Megan Muench, Thibault Alle, et al.
Biofactors (Oxford, England)|January 13, 2006
Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) StudyM Cristina Polidori, Domenico Praticó, Tiziana Ingegni, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 17, 2012
The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic miceBin Zhang, Jenna Carroll, John Q Trojanowski, et al.
Journal of Medicinal Chemistry|July 4, 2014
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathiesKevin Lou, Yuemang Yao, Adam T Hoye, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 15, 2010
Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathyKurt R Brunden, Bin Zhang, Jenna Carroll, et al.
Journal of Medicinal Chemistry|May 23, 2017
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative DiseasesAnne-Sophie Cornec, Ludovica Monti, Jane Kovalevich, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Evaluation of Oxetan-3-ol, Thietan-3-ol, and Derivatives Thereof as Bioisosteres of the Carboxylic Acid Functional GroupPierrik Lassalas, Killian Oukoloff, Vishruti Makani, et al.
Journal of Medicinal Chemistry|January 7, 2021
Evaluation of the Structure-Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidines Identifies New Candidates for Neurodegenerative TauopathiesKillian Oukoloff, Goodwell Nzou, Carmine Varricchio, et al.
Journal of Medicinal Chemistry|December 19, 2022
Microtubule-Stabilizing 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidines as Candidate Therapeutics for Neurodegenerative Disease: Matched Molecular Pair Analyses and Computational Studies Reveal New Structure-Activity InsightsThibault Alle, Carmine Varricchio, Yuemang Yao, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2024
A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's diseaseYuemang Yao, Megan Muench, Thibault Alle, et al.
Biofactors (Oxford, England)|January 13, 2006
Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) StudyM Cristina Polidori, Domenico Praticó, Tiziana Ingegni, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 17, 2012
The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic miceBin Zhang, Jenna Carroll, John Q Trojanowski, et al.
Journal of Medicinal Chemistry|July 4, 2014
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathiesKevin Lou, Yuemang Yao, Adam T Hoye, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 15, 2010
Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathyKurt R Brunden, Bin Zhang, Jenna Carroll, et al.
Journal of Medicinal Chemistry|May 23, 2017
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative DiseasesAnne-Sophie Cornec, Ludovica Monti, Jane Kovalevich, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Evaluation of Oxetan-3-ol, Thietan-3-ol, and Derivatives Thereof as Bioisosteres of the Carboxylic Acid Functional GroupPierrik Lassalas, Killian Oukoloff, Vishruti Makani, et al.
Journal of Medicinal Chemistry|January 7, 2021
Evaluation of the Structure-Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidines Identifies New Candidates for Neurodegenerative TauopathiesKillian Oukoloff, Goodwell Nzou, Carmine Varricchio, et al.
Journal of Medicinal Chemistry|December 19, 2022
Microtubule-Stabilizing 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidines as Candidate Therapeutics for Neurodegenerative Disease: Matched Molecular Pair Analyses and Computational Studies Reveal New Structure-Activity InsightsThibault Alle, Carmine Varricchio, Yuemang Yao, et al.
Pageof 4